Scholarlink

Abstract <p>Patients with end-stage renal disease (ESRD) develop brain iron deposition due to iron metabolism disorders induced by long-term hemodialysis. This abnormal iron accumulation accelerates cognitive impairment (CI) and neurodegenerative pathologies. Quantitative susceptibility mapping (QSM), a technique capable of precisely quantifying magnetic susceptibility, provides a novel perspective for the noninvasive and dynamic monitoring of cerebral iron distribution. Monitoring brain iron deposition using QSM facilitates the development of individualized clinical treatment strategies. This review systematically examines the application of QSM in studying brain iron deposition in hemodialysis patients, with a focus on analyzing the dynamic patterns of iron deposition pre- and post-dialysis and during follow-up periods. It further explores the relationship between QSM findings and iron metabolism dysregulation, blood-brain barrier (BBB) injury, and oxidative stress. Additionally, the predictive value of QSM for clinical neurological functional prognosis following iron chelation therapy is discussed.</p> Critical relevance statement <p>QSM studies on cerebral iron deposition in hemodialysis patients require further monitoring of its spatial-temporal dynamics and changes after iron chelation. Future research should focus on technical standardization, longitudinal tracking, and treatment response to establish a precision neuroimaging-guided framework.</p> Key Points <p><UnorderedList Mark="Bullet"> <ItemContent> <p>This review exploration is warranted to monitor the spatial distribution and dynamic changes of brain iron deposition in this population.</p> </ItemContent> <ItemContent> <p>The relationships between QSM findings and iron metabolism dysregulation, blood-brain barrier injury, and oxidative stress are explored.</p> </ItemContent> <ItemContent> <p>This review focuses on issues in the fields of technology standardization, longitudinal monitoring, and treatment responsiveness.</p> </ItemContent> </UnorderedList></p> Graphical Abstract <p></p>

错误：搜索内容不能为空，请输入英文关键词
错误：关键词超出字数限制，请精简
高级检索

Exploring the role of quantitative susceptibility mapping in assessing brain iron deposition in hemodialysis patients

  • 期刊论文

  • 出版模式：

    开放获取

  • 发表日期：

    2026年2月16日

查看全文
  • GuoLi Ren,
  • QingQing Nie,
  • Daliang Liu,
  • Bo Wang,
  • Xiao Gao,
  • XueHuan Liu,
  • Hao Wang,
  • Jun Liu

摘要

Abstract

Patients with end-stage renal disease (ESRD) develop brain iron deposition due to iron metabolism disorders induced by long-term hemodialysis. This abnormal iron accumulation accelerates cognitive impairment (CI) and neurodegenerative pathologies. Quantitative susceptibility mapping (QSM), a technique capable of precisely quantifying magnetic susceptibility, provides a novel perspective for the noninvasive and dynamic monitoring of cerebral iron distribution. Monitoring brain iron deposition using QSM facilitates the development of individualized clinical treatment strategies. This review systematically examines the application of QSM in studying brain iron deposition in hemodialysis patients, with a focus on analyzing the dynamic patterns of iron deposition pre- and post-dialysis and during follow-up periods. It further explores the relationship between QSM findings and iron metabolism dysregulation, blood-brain barrier (BBB) injury, and oxidative stress. Additionally, the predictive value of QSM for clinical neurological functional prognosis following iron chelation therapy is discussed.

Critical relevance statement

QSM studies on cerebral iron deposition in hemodialysis patients require further monitoring of its spatial-temporal dynamics and changes after iron chelation. Future research should focus on technical standardization, longitudinal tracking, and treatment response to establish a precision neuroimaging-guided framework.

Key Points

This review exploration is warranted to monitor the spatial distribution and dynamic changes of brain iron deposition in this population.

The relationships between QSM findings and iron metabolism dysregulation, blood-brain barrier injury, and oxidative stress are explored.

This review focuses on issues in the fields of technology standardization, longitudinal monitoring, and treatment responsiveness.

Graphical Abstract